
Xeon International, a Luxembourg based management firm, is pleased to announce its nomination as the arranger of the unregulated Promicol Licensing Fund.
The Promicol Licensing Fund is to be named Bio-Tec Limited Partners, an innovative unregulated investment vehicle focused on identifying and investing in promising technology licensing opportunities. Through its unique approach, the fund aims to generate attractive returns for investors while supporting the development and commercialisation of breakthrough technologies.
Xeon International’s deep expertise in company management and its track record of success in identifying high-potential opportunities make it an ideal choice to manage the Promicol Licensing Fund. The firm’s experienced team of professionals will leverage their knowledge and networks to identify and evaluate potential investments, ensuring that the fund is well-positioned to capture the most promising licensing opportunities.
“We are honored to have been nominated as the arranger and manager of Promicol Licensing Fund ,” said Mr. Yves Duponselle, CEO of Xeon International. “We believe that the fund’s unique focus on technology licensing offers an exciting opportunity for investors to participate in the growth and development of breakthrough technologies. Especially the future early detection of Cancer will be a game changer.
Our team is looking forward to leveraging our expertise to identify and invest in the most promising opportunities.”
The Promicol Licensing Fund is now open for investment, and Xeon International is actively seeking investors/ Licensees who are interested in participating in this innovative investment opportunity. For more information on the fund and how to invest, please contact Xeon International at info@xeon-international.com
About Promicol: Promicol B.V. is a Dutch biotech company that has been making significant
strides in the field of microbiological quality control. With a focus on providing
fast and accurate testing solutions, the company has been able to attract a diverse
range of clients, including large pharmaceutical companies, food manufacturers,
and research organizations.
About Xeon International: Xeon International is a Luxembourg based management firm that offers a wide range of solutions to institutional and individual investors. With offices in strategic parts of the world, the firm has a global reach and an excellent understanding of local markets. Xeon International is committed to delivering innovative investment solutions that help its clients achieve their financial goals.
Contact: Ben Kee – Managing Director – Xeon International Singapore – bk@xeon-international.com